Injectable Steroids

Mixos 250 mg Swiss Pharmaceuticals

Swiss Pharmaceuticals

70,00

In Stock (100 available)

Mixos 250 mg Swiss Pharmaceuticals (250 mg) — Swiss Pharmaceuticals presents this pharmaceutical-grade compound — this pharmaceutical-grade injectable compound is formulated …

100 in stock

This product is for laboratory research use only. Not for human consumption.

5+ −10%
10+ −15% Best price
Third-Party Lab Report HPLC verified
CoA available on request — email support@vitalquests.org with the batch code from your vial.
HPLC TestedBatch report available
No Labels on BoxPlain brown parcel
Pay the CourierCash on delivery only
Ships TodayOrder before 14:00
€85+ = free shipping
EU warehouse — no customs, no delays
Tracked via DHL / DPD / InPost

Description

Mixos 250 mg Swiss Pharmaceuticals — multi-ester testosterone blend from Swiss Pharmaceuticals at 250 mg. Staggered ester release combines rapid onset with sustained activity. High-concentration formulations reduce injection volume.

Key Benefits

  • Multi-ester blend — acute kick + long-tail coverage from one injection
  • Classic Sustanon / Omnadren formulation (prop + phenyl + iso + deca)
  • Twice-weekly pinning schedule covers all four ester kinetics
  • Behaves functionally like testosterone enanthate for cycle planning
  • Popular pharma-grade option where single-ester vials aren’t available
  • Each unit dosed at 250 mg — see Recommended Dosage below for protocol-specific intake

Recommended Dosage

Research dosing: 250–750 mg/week; TRT 100–200 mg/week. Split across at least 2 injections (Mon/Thu). Shorter esters in the blend push injection frequency — once-weekly produces noticeable troughs.

How It Works

Mixture of 4 testosterone esters: propionate (fast), phenylpropionate (short-medium), isocaproate (medium), decanoate (long). At the AR the active hormone is identical across esters; the blend provides staggered release kinetics for smoother coverage.

Pharmacokinetics

Composite release: propionate peaks in ~24 h, phenylpropionate ~2 days, isocaproate ~3–4 days, decanoate ~7–10 days. Net effect similar to enanthate but with a gentler peak. Steady-state in 4 weeks. PCT starts 2 weeks after last injection.

Potential Side Effects

Standard testosterone side-effect profile. Propionate fraction can cause PIP; some users prefer pure enanthate for tolerability. AI dose by bloodwork — hematocrit and E2 at week 6.

Cycle & Stacking Guide

Cycle base identical to enanthate: 12–16 weeks for mass/recomp, paired with secondary compounds per goal. Twice-weekly pinning mandatory. PCT (Clomid + Nolva) 14 days after last pin.

Manufacturer Notes

Swiss Pharmaceuticals is a research-compound producer with published batch QC data. Vials ship with tamper-evident caps and date-coded labels.

Storage & Handling

Store at recommended temperature (15–25°C; peptides and HGH at 2–8°C after reconstitution). Protect from light and moisture. Keep out of reach of children. For research and educational purposes only.

Reviews

There are no reviews yet.

Be the first to review “Mixos 250 mg Swiss Pharmaceuticals”

Your email address will not be published. Required fields are marked *